missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CA19-9 Monoclonal Antibody (121SLE)
Mouse Monoclonal Antibody
Brand: Invitrogen™ MA513275
This item is not returnable.
View return policy
Description
MA5-13275 targets CA19-9 in IHC (P) applications and shows reactivity with Human samples. The MA5-13275 immunogen is mucins from ovarian cyst.
Mucin glycoprotein is a Sialyl Lewis A structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewis A and/or Lewis B blood group antigens. In normal tissues, sialyl Lewis A antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands. Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas. Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery. When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings.
Specifications
| CA19-9 | |
| Monoclonal | |
| 0.2 mg/mL | |
| PBS with 0.2% BSA and 0.09% sodium azide; pH 7.4 | |
| Mouse | |
| Ammonium Sulfate Precipitation | |
| RUO | |
| Human | |
| Antibody | |
| IgM |
| Immunohistochemistry (Paraffin) | |
| 121SLE | |
| Unconjugated | |
| CA19 9; CA19.9; CA-19.9 | |
| Mucins from ovarian cyst. | |
| 500 μL | |
| Primary | |
| 4°C | |
| Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction